Sarcopenia vs body mass index (BMI) as a prognostic biomarker in patients with metastatic clear cell renal cell carcinoma (mCCRCC) in the era of first line immune checkpoint inhibitors (ICIs)

被引：0
|
作者：
La Course, Bryce Douglas
Orcutt, Delaney
Gross, Evan
Fintelmann, Florian J.
Master, Viraj A.
Hall, Evan Thomas
Wrobel, Maria Marta
Psutka, Sarah P.
机构：
[1] Univ Washington, Sch Med, Seattle, WA USA
[2] Vanderbilt Univ, Nashville, TN USA
[3] Harvard Med Sch, Massachusetts Gen Hosp, Div Thorac Imaging & Intervent, Boston, MA USA
[4] Emory Univ, Atlanta, GA USA
[5] Univ Washington, Fred Hutchinson Canc Ctr, Seattle, WA USA
[6] Ludwig Maximilians Univ Munchen, Munich, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16515
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Treatment Decisions for Metastatic Clear Cell Renal Cell Carcinoma in Older Patients: The Role of TKIs and Immune Checkpoint Inhibitors
    Esther, John
    Hale, Peter
    Hahn, Andrew W.
    Agarwal, Neeraj
    Maughan, Benjamin L.
    DRUGS & AGING, 2019, 36 (05) : 395 - 401
  • [22] First-line immune checkpoint inhibitors in advanced or metastatic renal cell carcinoma with sarcomatoid features
    Fontes-Sousa, Mario
    Calvo, Emiliano
    CANCER TREATMENT REVIEWS, 2022, 105
  • [23] Changes in the overall survival of patients with metastatic renal cell carcinoma in the era of immune-checkpoint inhibitors
    Adhikari, Arjab
    Sapkota, Supriya
    Gogia, Sopiko
    Ojbindra, K. C.
    CANCER EPIDEMIOLOGY, 2024, 92
  • [24] Outcomes of patients with metastatic clear cell renal cell carcinoma treated with second-line VEGFR-TKI after first-line immune checkpoint inhibitors.
    Shah, Amishi Yogesh
    Kotecha, Ritesh
    Lemke, Emily
    Chandramohan, Anuradha
    Chaim, Joshua
    Msaouel, Pavlos
    Xiao, Lianchun
    Gao, Jianjun
    Campbell, Matthew T.
    Zurita, Amado J.
    Wang, Jennifer
    Corn, Paul Gettys
    Jonasch, Eric
    Motzer, Robert J.
    Sharma, Padmanee
    Voss, Martin Henner
    Tannir, Nizar M.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
  • [25] Outcomes of patients with metastatic clear-cell renal cell carcinoma treated with second-line VEGFR-TKI after first-line immune checkpoint inhibitors
    Shah, A. Y.
    Kotecha, R. R.
    Lemke, E. A.
    Chandramohan, A.
    Chaim, J. L.
    Msaouel, P.
    Xiao, L.
    Gao, J.
    Campbell, M. T.
    Zurita, A. J.
    Wang, J.
    Corn, P. G.
    Jonasch, E.
    Motzer, R. J.
    Sharma, P.
    Voss, M. H.
    Tannir, N. M.
    EUROPEAN JOURNAL OF CANCER, 2019, 114 : 67 - 75
  • [26] Assessment of Immune Checkpoint Inhibitors and Genomic Alterations by Body Mass Index in Advanced Renal Cell Carcinoma
    Lalani, Aly-Khan A.
    Bakouny, Ziad
    Farah, Subrina
    Donskov, Frede
    Dudani, Shaan
    Heng, Daniel Y. C.
    Choueiri, Toni K.
    JAMA ONCOLOGY, 2021, 7 (05) : 773 - 775
  • [27] Ezrin is a prognostic biomarker in patients with clear cell metastatic renal cell carcinoma receiving sunitinib
    Cetin, Bulent
    Gonul, Ipek Isik
    Gumusay, Ozge
    Afsar, Baris
    Bilgetekin, Irem
    Ozet, Ahmet
    Uner, Aytug
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2021, 17 (02) : 408 - 413
  • [28] Validation of the Lung Immune Prognostic Index (LIPI) as a prognostic biomarker in metastatic renal cell carcinoma
    Carril-Ajuria, Lucia
    Lavaud, Pernelle
    Dalban, Cecile
    Negrier, Sylvie
    Gravis, Gwenaelle
    Motzer, Robert J.
    Chevreau, Christine
    Tannir, Nizar M.
    Oudard, Stephane
    McDermott, David F.
    Laguerre, Brigitte
    Hammers, Hans J.
    Barthelemy, Philippe
    Plimack, Elizabeth R.
    Borchiellini, Delphine
    Gross-Goupil, Marine
    Jiang, Ruiyun
    Lee, Chung-Wei
    de Silva, Heshani
    Rini, Brian I.
    Escudier, Bernard
    Albiges, Laurence
    EUROPEAN JOURNAL OF CANCER, 2024, 204
  • [29] Association of intra-tumoral microbiome and response to immune checkpoint inhibitors (ICIs) in patients with metastatic renal cell carcinoma (mRCC).
    Meza, Luis A.
    Choi, Yongwook
    Govindarajan, Ameish
    Dizman, Nazli
    Zengin, Zeynep Busra
    Hsu, Joann
    Salgia, Nicholas
    Salgia, Sabrina
    Malhotra, Jasnoor
    Chawla, Neal Shiv
    Chehrazi-Raffle, Alex
    Muddasani, Ramya
    Castro, Daniela V.
    Chan, Agnes
    Zhang, Guangfa
    Byron, Sara A.
    Highlander, Sarah K.
    Schork, Nick
    Pal, Sumanta K.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
  • [30] Association of body mass index (BMI) with survival outcomes in patients with metastatic renal cell carcinoma (mRCC)
    Goswamy, Rohit Vivek
    Yildirim, Ahmet
    Choi, Yujin
    Wei, Mengting
    Liu, Yuan
    Brown, Jacqueline T.
    Nazha, Bassel
    Martini, Dylan J.
    Hartman, Caitlin
    McClintock, Greta Russler
    Zhuang, Tony
    Kissick, Haydn
    Harris, Wayne Bernard
    Carthon, Bradley Curtis
    Kucuk, Omer
    Master, Viraj A.
    Bilen, Mehmet Asim
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
12345